, Tracking Stock Market Picks
Enter Symbol:
Horizon Pharma Inc (HZNP) [hlAlert]

up 18.92 %

Horizon Pharma Inc (HZNP) rated Buy with price target $32 by UBS

Posted on: Monday,  May 11, 2015  2:25 PM ET by UBS

UBS rated Buy Horizon Pharma Inc (NASDAQ: HZNP) on 05/11/2015. Previously UBS rated Buy Horizon Pharma Inc (NASDAQ: HZNP) on 03/31/2015.,
when the stock price was $25.79. Since then, Horizon Pharma Inc has gained 18.92% as of 01/19/2016's recent price of $30.67.
If you would have followed the previous UBS's recommendation on HZNP, you would have gained 18.92% of your investment in 294 days.

Horizon Pharma, Inc. (Horizon) is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company?s other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company?s distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/11/2015 2:25 PM Buy
28.39 32.00
as of 8/27/2015
1 Week down  -7.28 %
1 Month down  -10.50 %
3 Months up  7.99 %
1 YTD up  8.03 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/31/2015 1:25 PM Buy
25.79 30.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy